R. L. Cain

发表

The WEEE Directive: Information and Opportunities for Plastics Recycling

Vannessa Goodship, Neil Reynolds, R. L. Cain, 2002 .

Interleukin 1-induced pathophysiology: induction of cytokines, development of histopathologic changes, and immunopharmacologic intervention.

R. L. Cain, L. Butler, A. Bendele, 1989, Clinical immunology and immunopathology.

Neuroendocrine regulation of in vivo cytokine production and effects: I. In vivo regulatory networks involving the neuroendocrine system, interleukin-1 and tumor necrosis factor-α

R. L. Cain, S. Zuckerman, G. Evans, 1989, Journal of Neuroimmunology.

Effects of human parathyroid hormone (1-34), LY333334, on bone mass, remodeling, and mechanical properties of cortical bone during the first remodeling cycle in rabbits.

R. L. Cain, D. Burr, C. Turner, 2001, Bone.

Six‐Month Daily Administration of Parathyroid Hormone and Parathyroid Hormone—Related Protein Peptides to Adult Ovariectomized Rats Markedly Enhances Bone Mass and Biomechanical Properties: A Comparison of Human Parathyroid Hormone 1–34, Parathyroid Hormone‐Related Protein 1–36, and SDZ‐Parathyroid

R. L. Cain, M. Drezner, D. Burr, 2000, Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research.

In vivo regulation of apoptosis in metaphyseal trabecular bone of young rats by synthetic human parathyroid hormone (1-34) fragment.

R. L. Cain, J. Bidwell, J. Onyia, 2000, Bone.

Anabolic and catabolic bone effects of human parathyroid hormone (1-34) are predicted by duration of hormone exposure.

R. L. Cain, Masahiko Sato, J. Satterwhite, 2003, Bone.

Changes in Geometry and Cortical Porosity in Adult, Ovary-Intact Rabbits after 5 Months Treatment with LY333334 (hPTH 1-34)

R. L. Cain, D. Burr, T. Hirano, 2000, Calcified Tissue International.

The role of strain in the response of rapidly growing young male rat bones to parathyroid hormone.

R. L. Cain, J. Hock, M. Gunness, 2002, Journal of musculoskeletal & neuronal interactions.

Catabolic Effects of Continuous Human PTH (1-38) in Vivo Is Associated with Sustained Stimulation of RANKL and Inhibition of Osteoprotegerin and Gene-Associated Bone Formation.

R. L. Cain, T. Martin, S. Chandrasekhar, 2001, Endocrinology.

Comparison of Recombinant Human PTH(1–34) (LY333334) with a C‐Terminally Substituted Analog of Human PTH‐Related Protein(1–34) (RS‐66271): In Vitro Activity and In Vivo Pharmacological Effects in Rats

R. L. Cain, A. Harvey, S. Chandrasekhar, 1999, Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research.

Novel and Selective Small Molecule Stimulators of Osteoprotegerin Expression Inhibit Bone Resorption

R. L. Cain, T. Martin, S. Chandrasekhar, 2004, Journal of Pharmacology and Experimental Therapeutics.

Interleukin-2 induced systemic toxicity: induction of mediators and immunopharmacologic intervention.

R. L. Cain, L. Butler, A. Bendele, 1989, Immunopharmacology and immunotoxicology.

PINP: a serum biomarker of bone formation in the rat.

R. L. Cain, A. Geiser, J. Risteli, 2007, Bone.

Printed in U.S.A. Copyright © 2001 by The Endocrine Society Catabolic Effects of Continuous Human PTH (1–38) in Vivo Is Associated with Sustained Stimulation of RANKL and Inhibition of Osteoprotegerin and Gene-Associated Bone Formation

R. L. Cain, T. Martin, S. Chandrasekhar, 2022 .

Molecular Characterization of Gene Expression Changes in ROS 17/2.8 Cells Cultured in Diffusion Chambers In Vivo

R. L. Cain, J. Onyia, Y. Tu, 1999, Calcified Tissue International.

Anabolic Effects of Human Biosynthetic Parathyroid Hormone Fragment (1–34), LY333334, on Remodeling and Mechanical Properties of Cortical Bone in Rabbits

Toru Hirano, Masahiko Sato, R. L. Cain, 1999, Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research.

Analysis of early changes in the articular cartilage transcriptisome in the rat meniscal tear model of osteoarthritis: pathway comparisons with the rat anterior cruciate transection model and with human osteoarthritic cartilage.

R. L. Cain, A. Harvey, J. Onyia, 2010, Osteoarthritis and cartilage.

R. L. Cain, T. Martin, S. Chandrasekhar, 2022 .

Catabolic effects of continuous human PTH (1--38) in vivo is associated with sustained stimulation of RANKL and inhibition of osteoprotegerin and gene-associated bone formation.

R. L. Cain, J. Onyia, D. Halladay, 2001 .